PERTH, AUSTRALIA: September 02, 2011 – Phylogica Ltd (ASX: PYC, XETRA:PH7), a leading Australian peptide drug discovery company, is pleased to advise that a new research report has been prepared by RBS Morgans. The report is available on the Company website.
For further information please download PDF below:
